Literature DB >> 2563084

Antimycobacterial therapy ineffective in Crohn's disease after a year.

G Järnerot, P Rolny, G Wickbom, G Alemayehu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2563084     DOI： 10.1016/s0140-6736(89)91184-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Antibacterial therapy for Crohn's disease: a review emphasizing therapy directed against mycobacteria.

Authors:  K Hultén; A Almashhrawi; F A El-Zaatari; D Y Graham
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

2.  Controlled trial of anti-tuberculous chemotherapy for two years in Crohn's disease.

Authors:  G L Swift; E D Srivastava; R Stone; R D Pullan; R G Newcombe; J Rhodes; S Wilkinson; P Rhodes; G Roberts; B W Lawrie
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

3.  Controlled trial of antimycobacterial therapy in Crohn's disease. Clofazimine versus placebo.

Authors:  N H Afdhal; A Long; J Lennon; J Crowe; D P O'Donoghue
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

Review 4.  Antibiotics for the induction and maintenance of remission in ulcerative colitis.

Authors:  Morris Gordon; Vassiliki Sinopoulou; Ciaran Grafton-Clarke; Anthony K Akobeng
Journal:  Cochrane Database Syst Rev       Date:  2022-05-18

5.  Variable responses of formyl peptide receptor haplotypes toward bacterial peptides.

Authors:  Jeannie M Gripentrog; John S Mills; George J Saari; Heini M Miettinen
Journal:  Immunogenetics       Date:  2008-02-06       Impact factor: 2.846
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.